Mycogen (MYCO) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Mycogen (MYCO)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Galletta who wrote (70)	5/6/1998 4:22:00 PM
From: mike head	Read Replies (1) of 84

For the record... SAN DIEGO, May 6 /PRNewswire/ -- The Board of Directors of Mycogen Corporation (Nasdaq: MYCO) has appointed a committee of independent board members to respond to a request by Dow AgroSciences LLC, wholly owned subsidiary of The Dow Chemical Company, to amend an agreement between Dow AgroSciences and Mycogen. The amendment has been requested by Dow AgroSciences to allow it to begin discussions regarding the acquisition of the shares of common stock of Mycogen which it does not already own. Dow AgroSciences currently owns approximately 69 percent of Mycogen's common stock. The committee is retaining legal counsel and an investment banking firm to assist it in performing its duties. The committee will consider Dow AgroSciences' request and respond as appropriate. The process may take several weeks. Mycogen is a diversified agribusiness and biotechnology company that develops and markets seeds and value-added traits for genetically enhanced crops and provides crop protection products and services. For more information about Mycogen, please call 1-888-SEE-MYCO (1-888-733-6926) or visit Mycogen's website at www.mycogen.com. /CONTACT: Michael Sund

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next